Karin Walker
Director/Board Member at CYCLACEL PHARMACEUTICALS, INC.
Net worth: 11 106 $ as of 2024-05-30
Karin Walker active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PROTHENA CORPORATION PLC | Comptroller/Controller/Auditor | 2013-05-19 | - |
| CYCLACEL PHARMACEUTICALS, INC. | Director/Board Member | 2020-11-08 | - |
| Independent Dir/Board Member | 2020-11-08 | - |
Career history of Karin Walker
Former positions of Karin Walker
| Companies | Position | Start | End |
|---|---|---|---|
| VINCERX PHARMA, INC. | Director/Board Member | 2020-03-04 | 2020-12-22 |
| Independent Dir/Board Member | 2020-03-04 | 2020-12-22 | |
| AFFYMAX, INC. | Comptroller/Controller/Auditor | 2012-10-01 | 2013-04-30 |
| AMYRIS, INC. | Comptroller/Controller/Auditor | 2008-12-31 | 2012-08-31 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Comptroller/Controller/Auditor | 2006-05-31 | 2009-07-31 |
Ernst & Young US LLP
 Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA. | Corporate Officer/Principal | - | - |
Training of Karin Walker
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Statistics
International
| United States | 8 |
| Ireland | 2 |
Operational
| Comptroller/Controller/Auditor | 4 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 5 |
| Process Industries | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| AMYRIS, INC. | Process Industries |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
Ernst & Young US LLP
Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA. | Commercial Services |
- Stock Market
- Insiders
- Karin Walker
- Experience
